Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020

Detalhes bibliográficos
Autor(a) principal: Bellotto, Ghabriel Luiz
Data de Publicação: 2020
Outros Autores: Anschau, Bruna Spironello, Moereira, Camilla Scott, Silva, Juliane Toffoli, Teixeira, Kádima Nayara
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/10661
Resumo: The first infection caused by the new coronavirus occurred in China in December 2019.  Since then, the search for COVID-19 treatment has become the target of international research.  Although studies began shortly after the viral outbreak in China, publications of these studies were expected to increase worldwide after the World Health Organization's statement on the pandemic state of the disease. Thus, this study aimed to analyze the dynamics of scientific publications on the treatment of COVID-19 in the first half of 2020. For data collection, the MEDLINE platform was used through PubMed; the descriptors adopted were: "COVID-19 and Treatment" and "SARS-CoV-2 and Treatment", restricting the publication period from 01/01/2020 to 30/06/2020. Data showed that in January 2020, the initial phase of the pandemic, the number of publications on the subject was small compared to June, with the pandemic totally disseminated. The largest increase in the number of publications occurred between February and March (8.3 times higher). Regarding the number of countries involved in publications, it is observed that in January, three countries were involved; while in May there were 41 countries. In the period analyzed, China led with 152 publications, followed by the United States (141). This may be the result of the emergence of the first cases of the disease and the socioeconomic character of both, which despite the different political regimes, have scientific research as an important point for the continuity of development.
id UNIFEI_c2de0fc8f5c3d97288d235910aeaac21
oai_identifier_str oai:ojs.pkp.sfu.ca:article/10661
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020Estudio cienciométrico del dinámica de comportamiento de las publicaciones relativas al tratamiento del COVID-19 en el primer semestre de 2020Estudo cienciométrico da dinâmica comportamental das publicações referentes ao tratamento da COVID-19 no primeiro semestre de 2020COVID-19Scienciometric studyTreatment.COVID-19Estudio cienciométricoTratamiento.COVID-19Estudo cienciométricoTratamento.The first infection caused by the new coronavirus occurred in China in December 2019.  Since then, the search for COVID-19 treatment has become the target of international research.  Although studies began shortly after the viral outbreak in China, publications of these studies were expected to increase worldwide after the World Health Organization's statement on the pandemic state of the disease. Thus, this study aimed to analyze the dynamics of scientific publications on the treatment of COVID-19 in the first half of 2020. For data collection, the MEDLINE platform was used through PubMed; the descriptors adopted were: "COVID-19 and Treatment" and "SARS-CoV-2 and Treatment", restricting the publication period from 01/01/2020 to 30/06/2020. Data showed that in January 2020, the initial phase of the pandemic, the number of publications on the subject was small compared to June, with the pandemic totally disseminated. The largest increase in the number of publications occurred between February and March (8.3 times higher). Regarding the number of countries involved in publications, it is observed that in January, three countries were involved; while in May there were 41 countries. In the period analyzed, China led with 152 publications, followed by the United States (141). This may be the result of the emergence of the first cases of the disease and the socioeconomic character of both, which despite the different political regimes, have scientific research as an important point for the continuity of development.La primera infección causada por el nuevo coronavirus ocurrió en China, en diciembre de 2019. Desde entonces, la búsqueda por los tratamientos para la COVID-19 se convirtió en el objetivo de las investigaciones internacionales. Aunque los estudios han comenzado poco después del brote viral en China, el aumento de las publicaciones de estos estudios en todo el mundo se esperaba después de la declaración de la Organización Mundial de la Salud sobre el estado pandémico de la enfermedad. Así, este estudio tuvo como objetivo analizar la dinámica de las publicaciones científicas sobre el tratamiento de la COVID-19 en el primer semestre de 2020. Para la recolección de datos se utilizó la plataforma MEDLINE a través de PubMed; los descriptores adoptados fueron: “COVID-19 y Tratamiento” y “SARS-CoV-2 y Tratamiento”, restringiendo el período de publicación del 01/01/2020 al 30/06/2020. Los datos mostraron que en enero de 2020, fase inicial de la pandemia, el número de publicaciones sobre el tema fue diminuto en comparación con junio, con la pandemia totalmente diseminada. El mayor crecimiento en el número de publicaciones ocurrió entre febrero y marzo (8,3 veces mayor). Al que se refiere el número de países involucrados en publicaciones, se observa que en enero participaron tres países; mientras que en mayo había 41 países. En el período analizado, China lideró con 152 publicaciones, seguida del Estados Unidos (141). Esto puede ser resultado del surgimiento de los primeros casos de la enfermedad y del carácter socioeconómico de ambos, que a pesar de los diferentes regímenes políticos, tienen la investigación científica como un punto importante para la continuidad del desarrollo.A primeira infecção causada pelo novo coronavírus ocorreu na China, em dezembro de 2019.  Desde então, a busca por tratamentos para a COVID-19 tornou-se alvo de pesquisas internacionais.  Apesar dos estudos terem iniciado logo após o surto viral na China, era esperado o aumento das publicações desses estudos pelo mundo todo após a declaração da Organização Mundial de Saúde sobre o estado pandêmico da doença. Dessa forma, este estudo teve como objetivo analisar a dinâmica das publicações científicas sobre o tratamento da COVID-19 no primeiro semestre de 2020. Para a coleta de dados utilizou-se a plataforma MEDLINE por meio da PubMed; os descritores adotados foram: “COVID-19 and Treatment” e “SARS-CoV-2 and Treatment”, restringindo o período de publicação de 01/01/2020 a 30/06/2020. Dados mostraram que em janeiro de 2020, fase inicial da pandemia, o número de publicações sobre o tema foi ínfimo em relação a junho, com a pandemia totalmente disseminada. O maior crescimento no número de publicações ocorreu entre fevereiro e março (8,3 vezes maior). No que se refere ao número de países envolvidos em publicações, observa-se que em janeiro, três países estavam envolvidos; enquanto, em maio havia 41 países. No período analisado, a China liderou com 152 publicações, seguida pelos Estados Unidos (141). Isso pode ser resultado do surgimento dos primeiros casos da doença e  do caráter socioeconômico de ambos, que apesar dos distintos regimes políticos, têm a pesquisa científica como ponto importante para a continuidade do desenvolvimento.Research, Society and Development2020-12-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1066110.33448/rsd-v9i11.10661Research, Society and Development; Vol. 9 No. 11; e97591110661Research, Society and Development; Vol. 9 Núm. 11; e97591110661Research, Society and Development; v. 9 n. 11; e975911106612525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/10661/9557Copyright (c) 2020 Ghabriel Luiz Bellotto; Bruna Spironello Anschau; Camilla Scott Moereira; Juliane Toffoli Silva; Kádima Nayara Teixeirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBellotto, Ghabriel LuizAnschau, Bruna Spironello Moereira, Camilla Scott Silva, Juliane Toffoli Teixeira, Kádima Nayara2020-12-10T23:37:57Zoai:ojs.pkp.sfu.ca:article/10661Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:32:40.664094Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
Estudio cienciométrico del dinámica de comportamiento de las publicaciones relativas al tratamiento del COVID-19 en el primer semestre de 2020
Estudo cienciométrico da dinâmica comportamental das publicações referentes ao tratamento da COVID-19 no primeiro semestre de 2020
title Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
spellingShingle Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
Bellotto, Ghabriel Luiz
COVID-19
Scienciometric study
Treatment.
COVID-19
Estudio cienciométrico
Tratamiento.
COVID-19
Estudo cienciométrico
Tratamento.
title_short Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
title_full Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
title_fullStr Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
title_full_unstemmed Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
title_sort Scientometric study of dynamics of scientific publications on treatment of COVID-19 in the first half of 2020
author Bellotto, Ghabriel Luiz
author_facet Bellotto, Ghabriel Luiz
Anschau, Bruna Spironello
Moereira, Camilla Scott
Silva, Juliane Toffoli
Teixeira, Kádima Nayara
author_role author
author2 Anschau, Bruna Spironello
Moereira, Camilla Scott
Silva, Juliane Toffoli
Teixeira, Kádima Nayara
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Bellotto, Ghabriel Luiz
Anschau, Bruna Spironello
Moereira, Camilla Scott
Silva, Juliane Toffoli
Teixeira, Kádima Nayara
dc.subject.por.fl_str_mv COVID-19
Scienciometric study
Treatment.
COVID-19
Estudio cienciométrico
Tratamiento.
COVID-19
Estudo cienciométrico
Tratamento.
topic COVID-19
Scienciometric study
Treatment.
COVID-19
Estudio cienciométrico
Tratamiento.
COVID-19
Estudo cienciométrico
Tratamento.
description The first infection caused by the new coronavirus occurred in China in December 2019.  Since then, the search for COVID-19 treatment has become the target of international research.  Although studies began shortly after the viral outbreak in China, publications of these studies were expected to increase worldwide after the World Health Organization's statement on the pandemic state of the disease. Thus, this study aimed to analyze the dynamics of scientific publications on the treatment of COVID-19 in the first half of 2020. For data collection, the MEDLINE platform was used through PubMed; the descriptors adopted were: "COVID-19 and Treatment" and "SARS-CoV-2 and Treatment", restricting the publication period from 01/01/2020 to 30/06/2020. Data showed that in January 2020, the initial phase of the pandemic, the number of publications on the subject was small compared to June, with the pandemic totally disseminated. The largest increase in the number of publications occurred between February and March (8.3 times higher). Regarding the number of countries involved in publications, it is observed that in January, three countries were involved; while in May there were 41 countries. In the period analyzed, China led with 152 publications, followed by the United States (141). This may be the result of the emergence of the first cases of the disease and the socioeconomic character of both, which despite the different political regimes, have scientific research as an important point for the continuity of development.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-10
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/10661
10.33448/rsd-v9i11.10661
url https://rsdjournal.org/index.php/rsd/article/view/10661
identifier_str_mv 10.33448/rsd-v9i11.10661
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/10661/9557
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 11; e97591110661
Research, Society and Development; Vol. 9 Núm. 11; e97591110661
Research, Society and Development; v. 9 n. 11; e97591110661
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052782518206464